Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Lupin Limited announces the spin-off of its consumer healthcare division, LupinLife Consumer Healthcare Ltd., into a wholly ...

Axis Securities highlights mid-cap and small-cap stocks as the Indian market recovers. Key recommendations include Lupin and ...

Chouhan suggests buying Lupin at the current market price with a stop loss at Rs 1,940 and target price of Rs 2,035.

Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Wednesday, July 2, 2025, 11:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...

This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated ...

Pharmaceutical major Lupin Limited has announced the strategic spin-off of its consumer healthcare business, LupinLife ...

Indian equity benchmarks, BSE Sensex and NSE Nifty, are set to open on a flat note on Wednesday, mirroring mixed cues from ...

A host of corporate developments—from regulatory actions and major contracts to earnings, acquisitions, and management ...

Loteprednol Etabonate Ophthalmic Gel is bioequivalent to Lotemax SM Ophthalmic Gel of Bausch & Lomb Inc and will be ...

Lupin, Hero Moto, CLN Energy, Master Trust, SBI Card, Paras Defence, MOIL, NMDC are some of the top stocks to watch today ...

Auto majors Hyundai and Maruti Suzuki logged a 6% YoY dip in June sales. Lupin gained momentum with US FDA approval for its ...